Discharging Women with Advanced Ovarian Cancer on Home Parenteral Nutrition: Making and Implementing the Decision.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
07 Jan 2020
Historique:
received: 29 11 2019
accepted: 25 12 2019
entrez: 16 1 2020
pubmed: 16 1 2020
medline: 24 10 2020
Statut: epublish

Résumé

Increasingly, patients with advanced ovarian cancer in bowel obstruction are receiving home parenteral nutrition (HPN). Little is known about making and implementing the decision. This study explored the decision-making process for HPN and investigated the barriers and facilitators to implementation. This was a qualitative study underpinned by phenomenology involving 93 longitudinal in-depth interviews with 20 patients, their relatives and healthcare professionals, over 15 months. Participants were interviewed a maximum of four times. Interview transcripts were analysed thematically as per the techniques of Van Manen. We found variance between oncologists and patients regarding ownership of the HPN decision. The oncologists believed they were engaging in a shared decision-making process. However, patients felt that the decision was oncologist-driven. Nevertheless, they were content to have the treatment, when viewing the choice as either HPN or death. In implementing the decision, the principal mutable barrier to a timely discharge was communication difficulties across professional disciplines and organisations. Facilitators included developing a single point-of-contact between organisations, improving communication and implementing standardised processes. Oncologists and patients differ in their perceptions of how treatment decisions are made. Although patients are satisfied with the process, it might be beneficial for healthcare professionals to check patients' understanding of treatment.

Identifiants

pubmed: 31936057
pii: nu12010166
doi: 10.3390/nu12010166
pmc: PMC7019843
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Marie Curie
ID : MCCC-RP-16-A21001
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Soc Sci Med. 1999 Sep;49(5):651-61
pubmed: 10452420
BMC Palliat Care. 2019 Dec 29;18(1):120
pubmed: 31884962
Med Oncol. 2011 Mar;28(1):83-8
pubmed: 20107935
J R Soc Med. 2009 Nov;102(11):481-8
pubmed: 19875537
Patient Educ Couns. 2015 Sep;98(9):1046-57
pubmed: 26138158
J Women Aging. 2006;18(4):31-47
pubmed: 17200062
Hum Resour Health. 2013 May 10;11:19
pubmed: 23663329
J Gen Intern Med. 2012 Dec;27(12):1649-56
pubmed: 22829294
Clin Nutr. 2009 Aug;28(4):445-54
pubmed: 19477052
J Health Serv Res Policy. 2004 Oct;9(4):218-25
pubmed: 15509407
J Clin Nurs. 2015 Jun;24(11-12):1676-85
pubmed: 25736984
Support Care Cancer. 2014 Jul;22(7):1867-74
pubmed: 24557011
Cochrane Database Syst Rev. 2018 Aug 10;8:CD012812
pubmed: 30095168
Clin Nutr. 2004 Dec;23(6):1280-7
pubmed: 15556250
JAMA. 1999 Nov 3;282(17):1670-2
pubmed: 10553796
Health Expect. 2015 Dec;18(6):3302-12
pubmed: 25496598
Cochrane Database Syst Rev. 2016 Jan 27;(1):CD000313
pubmed: 26816297
J Gen Intern Med. 2005 Jun;20(6):531-5
pubmed: 15987329
Qual Health Res. 2016 Nov;26(13):1802-1811
pubmed: 27340178
J Interprof Care. 2016 Nov;30(6):795-803
pubmed: 27436606

Auteurs

Anne Marie Sowerbutts (AM)

Faculty of Medicine, Biology and Health, and Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester M13 9PL, UK.

Simon Lal (S)

Salford Royal NHS Foundation Trust, Manchester M6 8HD, UK.

Jana Sremanakova (J)

Faculty of Medicine, Biology and Health, and Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester M13 9PL, UK.

Andrew R Clamp (AR)

Faculty of Medicine, Biology and Health, and Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester M13 9PL, UK.
The Christie NHS Foundation Trust, Manchester M20 4BX, UK.

Gordon C Jayson (GC)

Faculty of Medicine, Biology and Health, and Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester M13 9PL, UK.
The Christie NHS Foundation Trust, Manchester M20 4BX, UK.

Antje Teubner (A)

Salford Royal NHS Foundation Trust, Manchester M6 8HD, UK.

Lisa Hardy (L)

Wythenshawe Hospital, University Hospital of South Manchester, Manchester University NHS Foundation Trust, Manchester M23 9LT, UK.

Chris Todd (C)

Faculty of Medicine, Biology and Health, and Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester M13 9PL, UK.
Wythenshawe Hospital, University Hospital of South Manchester, Manchester University NHS Foundation Trust, Manchester M23 9LT, UK.

Anne-Marie Raftery (AM)

The Christie NHS Foundation Trust, Manchester M20 4BX, UK.

Eileen Sutton (E)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2PS, UK.

Sorrel Burden (S)

Faculty of Medicine, Biology and Health, and Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester M13 9PL, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH